California Public Employees Retirement System Atea Pharmaceuticals, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$19.22 - $59.08 $500,315 - $1.54 Million	-26,031 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$41.42 - $88.44 $101,106 - $215,882	-2,441 Reduced 8.57%	26,031 $1.61 Million
Q4 2020 Feb 02, 2021	BUY	$26.36 - $41.78 $750,521 - $1.19 Million	28,472 New	28,472 $1.19 Million

Others Institutions Holding AVIR

# of Institutions

112

Shares Held

52.4M

Call Options Held

900

Put Options Held

126K

Black Rock Inc. New York, NY

9.12M
Shares

$28.8 Million
0.0% of portfolio
Bml Capital Management, LLC Zionsville, IN

6.65M
Shares

$21 Million
13.11% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.44M
Shares

$17.2 Million
0.79% of portfolio
Vanguard Group Inc Valley Forge, PA

4.85M
Shares

$15.3 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

4.61M
Shares

$14.6 Million
1.31% of portfolio

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $263M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account